BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15270615)

  • 1. Loss of heterozygosity patterns of sclerosing hemangioma of the lung and bronchioloalveolar carcinoma indicate a similar molecular pathogenesis.
    Dacic S; Sasatomi E; Swalsky PA; Kim DW; Finkelstein SD; Yousem SA
    Arch Pathol Lab Med; 2004 Aug; 128(8):880-4. PubMed ID: 15270615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal selection of adenocarcinoma of the lung as determined by loss of heterozygosity.
    Dacic S; Finkelstein SD; Yousem SA
    Exp Mol Pathol; 2005 Apr; 78(2):135-9. PubMed ID: 15713439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsatellite and EGFR, HER2 and K-RAS analyses in sclerosing hemangioma of the lung.
    Sartori G; Bettelli S; Schirosi L; Bigiani N; Maiorana A; Cavazza A; Rossi G
    Am J Surg Pathol; 2007 Oct; 31(10):1512-20. PubMed ID: 17895751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic profile of cumulative mutational damage associated with early pulmonary adenocarcinoma: bronchioloalveolar carcinoma vs. stage I invasive adenocarcinoma.
    Sasatomi E; Johnson LR; Aldeeb DN; Lomago DM; Thompson JW; Swalsky PA; Luketich JD; Fernando HC; Finkelstein SD; Yousem SA
    Am J Surg Pathol; 2004 Oct; 28(10):1280-8. PubMed ID: 15371943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of genetic and epigenetic alterations at 11 tumor suppressor loci in pulmonary sclerosing hemangioma and adenocarcinoma.
    Lee HJ; Jang SJ; Chun SM; Park SI; Kim DK; Choi J
    Exp Lung Res; 2011 Aug; 37(6):344-53. PubMed ID: 21649526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FHIT and p53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutations.
    Marchetti A; Pellegrini S; Bertacca G; Buttitta F; Gaeta P; Carnicelli V; Nardini V; Griseri P; Chella A; Angeletti CA; Bevilacqua G
    J Pathol; 1998 Mar; 184(3):240-6. PubMed ID: 9614374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchioloalveolar lung carcinomas: K-ras mutations are constant events in the mucinous subtype.
    Marchetti A; Buttitta F; Pellegrini S; Chella A; Bertacca G; Filardo A; Tognoni V; Ferreli F; Signorini E; Angeletti CA; Bevilacqua G
    J Pathol; 1996 Jul; 179(3):254-9. PubMed ID: 8774479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotypic analysis of pulmonary Langerhans cell histiocytosis.
    Dacic S; Trusky C; Bakker A; Finkelstein SD; Yousem SA
    Hum Pathol; 2003 Dec; 34(12):1345-9. PubMed ID: 14691922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathogenesis of pulmonary carcinosarcoma as determined by microdissection-based allelotyping.
    Dacic S; Finkelstein SD; Sasatomi E; Swalsky PA; Yousem SA
    Am J Surg Pathol; 2002 Apr; 26(4):510-6. PubMed ID: 11914631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucinous cells in type 1 pulmonary congenital cystic adenomatoid malformation as mucinous bronchioloalveolar carcinoma precursors.
    Lantuejoul S; Nicholson AG; Sartori G; Piolat C; Danel C; Brabencova E; Goldstraw P; Brambilla E; Rossi G
    Am J Surg Pathol; 2007 Jun; 31(6):961-9. PubMed ID: 17527088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity patterns provide fingerprints for genetic heterogeneity in multistep cancer progression of tobacco smoke-induced non-small cell lung cancer.
    Pan H; Califano J; Ponte JF; Russo AL; Cheng KH; Thiagalingam A; Nemani P; Sidransky D; Thiagalingam S
    Cancer Res; 2005 Mar; 65(5):1664-9. PubMed ID: 15753360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between genetic alterations and histopathological subtypes in bronchiolo-alveolar carcinoma and atypical adenomatous hyperplasia of the lung.
    Yamasaki M; Takeshima Y; Fujii S; Kitaguchi S; Matsuura M; Tagawa K; Inai K
    Pathol Int; 2000 Oct; 50(10):778-85. PubMed ID: 11107049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LKB1 mutations frequently detected in mucinous bronchioloalveolar carcinoma.
    Osoegawa A; Kometani T; Nosaki K; Ondo K; Hamatake M; Hirai F; Seto T; Sugio K; Ichinose Y
    Jpn J Clin Oncol; 2011 Sep; 41(9):1132-7. PubMed ID: 21816872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity in clonal evolution with genetic progression and divergence in spindle cell carcinoma of the gallbladder.
    Arakawa A; Fujii H; Matsumoto T; Hirai S; Suda K
    Hum Pathol; 2004 Apr; 35(4):418-23. PubMed ID: 15116321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of accumulated allele loss between primary tumor and lymph node metastasis in stage II non-small cell lung carcinoma: implications for the timing of lymph node metastasis and prognostic value.
    Sasatomi E; Finkelstein SD; Woods JD; Bakker A; Swalsky PA; Luketich JD; Fernando HC; Yousem SA
    Cancer Res; 2002 May; 62(9):2681-9. PubMed ID: 11980668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papillary adenocarcinoma of the lung is a more advanced adenocarcinoma than bronchioloalveolar carcinoma that is composed of two distinct histological subtypes.
    Jian Z; Tomizawa Y; Yanagitani N; Iijima H; Sano T; Nakajima T
    Pathol Int; 2005 Oct; 55(10):619-25. PubMed ID: 16185291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.
    Sanz-Ortega J; Saez MC; Sierra E; Torres A; Balibrea JL; Hernando F; Sanz-Esponera J; Merino MJ
    J Pathol; 2001 Nov; 195(4):429-34. PubMed ID: 11745674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of allelic loss of synchronous adenocarcinomas of the lung.
    Dacic S; Ionescu DN; Finkelstein S; Yousem SA
    Am J Surg Pathol; 2005 Jul; 29(7):897-902. PubMed ID: 15958854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
    Gradowski JF; Mantha GS; Hunt JL; Dacic S
    Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative mutational analysis of pulmonary scar epithelium, bronchioloalveolar carcinomas, and invasive well-differentiated pulmonary adenocarcinomas: a molecular approach to diagnostically challenging cases.
    Sheikh HA; Sasatomi E; Finkelstein S; Yousem SA
    Am J Surg Pathol; 2005 Oct; 29(10):1267-73. PubMed ID: 16160467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.